Company profile for Second Life Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Second Life Therapeutics is a New York-based clinical-stage biotech pioneering "New Biology" with SL-28 (SLT-001), an off-the-shelf, allogeneic cell therapy using proprietary Teazeled receptor-activated leukocytes from healthy donors. Targets solid tumors (pancreatic cancer preclinical; Phase 1/2 advanced solids NCT07341737). Non-genetically modified, cryo-preservable approach shifts cancer treatment paradigms—first oncology...
Second Life Therapeutics is a New York-based clinical-stage biotech pioneering "New Biology" with SL-28 (SLT-001), an off-the-shelf, allogeneic cell therapy using proprietary Teazeled receptor-activated leukocytes from healthy donors. Targets solid tumors (pancreatic cancer preclinical; Phase 1/2 advanced solids NCT07341737). Non-genetically modified, cryo-preservable approach shifts cancer treatment paradigms—first oncology, then broader applications.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
180 Varick str, 6 fl | New York, 10014
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty